Generic Lenacapavir Approval for HIV Prevention Raises Hope in Low-Income Nations

(MedPage Today) -- The FDA has approved a generic version of lenacapavir (Yeztugo), the world's only twice-a-year shot to prevent HIV -- a big step toward making the drug available inexpensively and more quickly in 120 low- and middle-income...